Avalon GloboCare Advances Next Generation Cellular Immunotherapy with FLASH-CAR™ Technology for Blood Cancers May 8, 2020
Healthcare Roundup – White House not on board with CDC reopening guidelines, Gilead confirms remdesivir approval in Japan for severe COVID-19 May 7, 2020 Life Science
Healthcare Roundup – White House coronavirus task force to ‘continue indefinitely’, Sinovac COVID-19 vaccine shows positive effect May 6, 2020 Life Science
Naturally Splendid Signs Sales Distribution Agreement with Ecotrend Ecologics May 6, 2020 Life Science
Healthcare Roundup – FDA OKs emergency use of PerkinElmer COVID-19 blood test, Athersys up 3% premarket May 5, 2020 Life Science
Healthcare Roundup – Vir and Alnylam identify inhalable drug candidate for COVID-19, AmerisourceBergen eyes Walgreens’ drug distribution operation May 5, 2020 Life Science
Utrecht University, Erasmus Medical Center and Harbour BioMed Researchers Report Discovery of Antibody that Blocks Novel Coronavirus SARS-CoV-2 Infection in Cells May 4, 2020 Life Science
Ascentage Pharma’s Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia May 4, 2020 Life Science
Healthcare Roundup – FDA OKs subcutaneous version of J&J’s Darzalex, European advisory group backs expanded label of Gilead’s Harvoni May 1, 2020 Life Science
Healthcare Roundup – AstraZeneca teams up with Oxford U. on COVID-19 vaccine, Molina to buy Magellan May 1, 2020 Life Science
Healthcare Roundup – Gilead Sciences Q1 2020 Earnings Preview, FDA OKs expanded use of Glaxo’s Zejula Apr 30, 2020 Life Science
Naturally Splendid Extends Filing Deadline for Annual Financial Statements and MD&A Apr 28, 2020 Life Science
Healthcare Roundup – Roche’s entrectinib OK’d in Canada, Sarepta up 5% premarket on COVID-19 plan Apr 28, 2020 Life Science
Avalon GloboCare Partners with HydroPeptide, a Leader in Epigenetics Skin Care, to Accelerate Regenerative ACTEX™ Product Development and Commercialization Apr 28, 2020 Life Science
Healthcare Roundup —— Sorrento Therapeutics in deal for up to $250M, Moderna submits IND application for Phase 2 COVID-19 study Apr 27, 2020 Life Science
